Tokyo - Delayed Quote JPY

Mani, Inc. (7730.T)

1,220.00
+7.50
+(0.62%)
As of 12:45:57 PM GMT+9. Market Open.
Loading Chart for 7730.T
  • Previous Close 1,212.50
  • Open 1,237.00
  • Bid 1,220.00 x --
  • Ask 1,222.00 x --
  • Day's Range 1,219.50 - 1,237.50
  • 52 Week Range 1,044.50 - 2,161.00
  • Volume 113,300
  • Avg. Volume 554,289
  • Market Cap (intraday) 120.173B
  • Beta (5Y Monthly) 0.18
  • PE Ratio (TTM) 19.92
  • EPS (TTM) 61.23
  • Earnings Date Jul 3, 2025 - Jul 7, 2025
  • Forward Dividend & Yield 46.00 (3.79%)
  • Ex-Dividend Date Aug 28, 2025
  • 1y Target Est 1,513.33

Mani, Inc. engages in the manufacture and distribution of medical devices and dental instruments in Japan and internationally. The company offers surgical instruments, such as maniplers, vessel knives, ENT knives, stainless wire needles, maniceps, septum stitch, and stent graft metal skeleton; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for vitrectomy. It also provides surgical eyeless, eyed, taper point, cutting, ophthalmic needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. In addition, the company imports and sells medical devices. The company was founded in 1956 and is headquartered in Utsunomiya, Japan.

www.mani.co.jp

4,154

Full Time Employees

August 31

Fiscal Year Ends

Recent News: 7730.T

View More

Performance Overview: 7730.T

Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

7730.T
31.72%
Nikkei 225 (^N225)
4.06%

1-Year Return

7730.T
34.04%
Nikkei 225 (^N225)
0.25%

3-Year Return

7730.T
9.26%
Nikkei 225 (^N225)
44.83%

5-Year Return

7730.T
46.86%
Nikkei 225 (^N225)
88.86%

Compare To: 7730.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7730.T

View More

Valuation Measures

Annual
As of 5/12/2025
  • Market Cap

    119.43B

  • Enterprise Value

    100.88B

  • Trailing P/E

    19.79

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.06

  • Price/Book (mrq)

    2.24

  • Enterprise Value/Revenue

    3.43

  • Enterprise Value/EBITDA

    9.61

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.52%

  • Return on Assets (ttm)

    9.13%

  • Return on Equity (ttm)

    11.50%

  • Revenue (ttm)

    29.42B

  • Net Income Avi to Common (ttm)

    6.03B

  • Diluted EPS (ttm)

    61.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.63B

  • Total Debt/Equity (mrq)

    0.14%

  • Levered Free Cash Flow (ttm)

    -1.62B

Research Analysis: 7730.T

View More

Company Insights: 7730.T

Research Reports: 7730.T

View More

People Also Watch